Brooke Eby was thirty-three when ALS arrived, and thirty-seven when it finished what it came to do — but in the four years between, she refused the silence the disease so often demands. Diagnosed in 2022 with a condition that erases the body while leaving the mind to watch, she became a public voice for thousands navigating that particular cruelty, wielding humor where others might have wielded only grief. Her death on October 2, 2026, is a reminder that some of the most important work human beings do is simply refusing to disappear quietly.
Brooke Eby, A.L.S. Advocate Who Found Humor in Illness, Dies at 37
Brooke Eby died from ALS at age 37, four years after her diagnosis at age 33.
She made people laugh. She made them listen.
Mark
What made Eby's advocacy different from other people who've had ALS?
Mimi
She used humor. That's not common in how we talk about terminal illness. Most advocacy around ALS is either very clinical or very inspirational. She did neither.
Luke
Do we know specifics about what she said or did? The source material is quite thin—we have her diagnosis date, her age, and that she died, but not much about the actual advocacy work.
Mimi
That's fair. The reporting doesn't give us examples of her wit or specific campaigns she led. We know she was vocal and witty, but we're taking that on faith.
Mark
Why does that matter for understanding her impact?
Luke
Because impact is measured in specifics. Did she change policy? Start a foundation? Reach millions online? We don't know. We know she was known for it, but known by whom, and to what effect?
Mimi
She made people with ALS feel less alone. That's real, even if it's hard to quantify. Sometimes the impact of a voice is in the conversations it enables, not in legislation passed.
Mark
So her death at 37, just four years after diagnosis—that's the story?
Luke
It is and it isn't. The story is that she lived those four years publicly, deliberately, in a way most people don't. But we're missing the details that would let us understand how.
Mimi
The details might not exist in the public record yet. Sometimes a life's impact takes time to measure.
Le Pouls
- ALS gave Brooke Eby a statistical window of two to five years — she used every month of her four to speak as loudly as the disease would allow.
- The tension at the heart of ALS is brutal: the mind stays fully present while the body is methodically taken away, and Eby named that cruelty plainly, without softening it for comfort.
- Rather than accept the inspirational script often imposed on the ill, she brought sharp, unsentimental humor to her advocacy — making people laugh and, in doing so, making them truly listen.
- Her voice helped patients and families find language for experiences that often go unspoken, building a community of recognition around a disease most of the public barely knows exists.
- She died at 37, and while that voice is now gone, the awareness she raised and the people she made feel less alone remain — as does the urgent, unfinished work of finding a cure.
Brooke Eby was thirty-three when ALS arrived, and thirty-seven when it finished what it came to do — but in the four years between, she refused the silence the disease so often demands. Diagnosed in 2022 with a condition that erases the body while leaving the mind to watch, she became a public voice for thousands navigating that particular cruelty, wielding humor where others might have wielded only grief. Her death on October 2, 2026, is a reminder that some of the most important work human beings do is simply refusing to disappear quietly.
Brooke Eby was 33 years old when she was diagnosed with ALS in 2022. The disease attacks the nerve cells governing voluntary movement, progressing without mercy — most patients live two to five years. She would live four.
What set her apart was not the diagnosis but her response to it. Rather than withdraw, Eby became a public voice for people living with ALS's particular cruelty: the slow erasure of the body while the mind remains fully aware. She spoke with wit and directness, refusing the softened, inspirational framing that illness narratives so often receive. She made people laugh. She made them listen.
Her advocacy was a form of resistance — against silence, against despair, against the tendency to let a disease define the conversation entirely. She talked openly about the indignities and absurdities of her experience, and in doing so gave other patients and families a language for their own. She also brought wider attention to ALS itself, a devastating disease that remains poorly understood by the general public.
She died on October 2, 2026, at 37. ALS kills roughly 5,000 Americans each year, most diagnosed in their 40s and 50s, making her diagnosis at 33 relatively rare. There is no cure, no meaningful way to slow the disease, and no known cause in most cases. Research continues slowly while patients and families wait. Some, like Eby, use that time to speak. Her death underscores both the urgency of finding answers and the irreplaceable value of voices willing to face the darkness without flinching.
Brooke Eby was 33 years old when she received her diagnosis of ALS in 2022. The disease, which attacks the nerve cells that control voluntary muscle movement, typically progresses rapidly and without mercy. Most people live only two to five years after diagnosis. She would live four.
What distinguished her in those four years was not the diagnosis itself—thousands receive one each year in the United States—but what she chose to do with the time remaining. Rather than retreat into privacy, Eby became a public voice for people navigating the particular cruelty of ALS: the slow erasure of the body while the mind remains intact and aware. She spoke with wit and directness about her own experience, refusing the kind of inspirational softening that often surrounds illness narratives. She made people laugh. She made them listen.
ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that gradually paralyzes its victims. The muscles weaken and atrophy. Speech becomes difficult, then impossible. Swallowing fails. Eventually, breathing stops. There is no cure. There is no way to slow it down significantly. For most patients, the diagnosis is a sentence with a known expiration date.
Eby's advocacy work became a form of resistance against that silence. She spoke publicly about living with the disease, about the indignities and the absurdities, about what it meant to watch your own body become a stranger. She did this with humor—sharp, unsentimental humor that acknowledged the darkness without drowning in it. In doing so, she gave other patients and their families a language for their own experiences. She also raised awareness about ALS itself, a disease that remains relatively unknown to the general public despite its devastating effects.
She died on October 2, 2026, at the age of 37. Four years had passed since her diagnosis. Four years to live a life that many would have spent in despair or denial. Instead, she spent it speaking, advocating, connecting with others who faced the same diagnosis. Her death marks the end of that particular voice, but the work she did—the conversations she started, the awareness she raised, the people she helped feel less alone—continues.
ALS kills approximately 5,000 Americans each year. Most are diagnosed in their 40s and 50s, making Eby's diagnosis at 33 relatively unusual. The disease has no known cause in most cases, no prevention, and no cure. Research continues, but progress is slow. Families and patients wait. Some, like Eby, use the waiting to speak. Her death underscores both the urgency of that research and the value of the voices—witty, honest, unafraid—that refuse to let the disease define the conversation entirely.
Citations marquantes
She spoke publicly about living with the disease, about the indignities and the absurdities, about what it meant to watch your own body become a stranger.— Narrative account of her advocacy approach
Envie de l'histoire complète ?
Lire l'original sur The New York Times ↗